UnknownNot Applicable

Impact of Environmental Exposures on Tumor Risk in Subjects at Risk of Hereditary SDHx Paraganglioma

100 participantsStarted 2022-03-01

Plain-language summary

The main objective of the pilot phase of PGLEXPO will be to assess the faisability and to precise methodology of a case-control study designed for testing the impact of environmental and professional exposures on the tumoral risk in SDHx-mutation carriers

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Cases: SDHx mutation carriers diagnosed for a SDHx-related tumor
✓. Controls: SDHx mutation carriers with no SDHx-related tumor

What they're measuring

Feasability of the protocol of a national case/control study (PGL.EXPO2)

Timeframe: 2 years

Trial details

NCT IDNCT04481152

SponsorAssistance Publique - Hôpitaux de Paris

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-09-01

Contact for this trial

Anne-Paule GIMENEZ-ROQUEPLO, MD, PhD

33 1 56 09 38 81 anne-paule.gimenez-roqueplo@aphp.fr

View on ClinicalTrials.gov More Genetic Predisposition trials